P-1382. Stress hyperglycemia during tuberculosis treatment and rate of sputum culture conversion

Abstract Background Tuberculosis (TB) is the leading cause of infectious disease mortality worldwide. Diabetes increases the risk of poor TB treatment outcomes and is increasingly prevalent in high-TB burden settings. However, whether TB-induced stress hyperglycemia impacts TB treatment outcomes is unclear. We compared TB culture conversion rates among stress hyperglycemic participants to those with diabetes/pre-diabetes or euglycemia. Methods This is an on-going prospective cohort study of adults with newly-diagnosed pulmonary TB disease in the country of Georgia. At treatment initiation, participants were categorized as having diabetes (DM)/prediabetes (pre-DM), euglycemia, or stress hyperglycemia (defined as hemoglobin A1c [HbA1c] ≥ 5.7% or fasting blood glucose [FBG] ≥ 100 mg/dl at TB treatment start and HbA1c < 5.7% or FBG < 100 mg/dl within 2 months). Culture conversion was defined as two consecutive monthly negative Mtb cultures with no subsequent positive cultures. Culture conversion rates were compared by glycemic status using Kaplan Meier curves and hazards regression. Results Among 225 participants (64% of target enrollment) with culture data available to date: median age was 40 years (IQR 29-54), median BMI was 20.7 kg/m2 (IQR 18.6-23.8), and 38% were female. At enrollment, 43% had stress hyperglycemia, 17% had DM or pre-DM, and 40% had euglycemia. Overall, 200 participants (89%) achieved culture conversion by 2 months, with the lowest proportion of culture conversion in the stress hyperglycemia group (82% converted, vs 89% DM/pre-DM and 96% euglycemic; p=0.01). Median time to culture conversion was 58 days (IQR 30-62) among participants with stress hyperglycemia, compared to 59 days (IQR 31-72) among DM/pre-DM and 51 days (IQR 30-62) among euglycemic participants (Figure 1; p=0.10). After adjusting for age, sex, and baseline BMI, participants with stress hyperglycemia (HR 0.75, 95%CI 0.5-1.0) and DM/pre-DM (HR 0.72, 95%CI 0.5-1.1) had reduced culture conversion rates compared to euglycemic participants. Conclusion In preliminary analysis, we found >40% of participants had stress hyperglycemia at TB treatment initiation. Participants with stress hyperglycemia trended to have reduced culture conversion rates compared to those with euglycemia. Disclosures Francisco J. Pasquel, MD, MPH, Dexcom: Grant/Research Support|Dexcom: Grant/Research Support|Dexcom: Honoraria|Ideal Medical Technologies: Grant/Research Support|Insulet: Grant/Research Support|Novo Nordisk: Grant/Research Support|Tandem Diabetes Care: Grant/Research Support

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2026-01-01
DOI
https://doi.org/10.1093/ofid/ofaf695.1569
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

P-1382. Stress hyperglycemia during tuberculosis treatment and rate of sputum culture conversion

Matthew James Magee, Jeffrey Michael Collins, Angie Campbell, Hardy Kornfeld et al.
Open Forum Infectious Diseases
Tuberculosis Research and Epidemiology
article

P-1382. Stress hyperglycemia during tuberculosis treatment and rate of sputum culture conversion

Matthew James Magee, Jeffrey Michael Collins, Angie Campbell, Hardy Kornfeld, Dzigbordi Kamasa-Quashie, Russell Ryan Kempker, Francisco J. Pasquel, Lorissa J. Smulan, Fay Willis, Victoria C Ontiveros, Inga Davitadze, A Nichole Evans, Tekla Madzgharashvili, Maia Kipiani, Neel Gandhi
article en

Abstract

Abstract Background Tuberculosis (TB) is the leading cause of infectious disease mortality worldwide. Diabetes increases the risk of poor TB treatment outcomes and is increasingly prevalent in high-TB burden settings. However, whether TB-induced stress hyperglycemia impacts TB treatment outcomes is unclear. We compared TB culture conversion rates among stress hyperglycemic participants to those with diabetes/pre-diabetes or euglycemia. Methods This is an on-going prospective cohort study of adults with newly-diagnosed pulmonary TB disease in the country of Georgia. At treatment initiation, participants were categorized as having diabetes (DM)/prediabetes (pre-DM), euglycemia, or stress hyperglycemia (defined as hemoglobin A1c [HbA1c] ≥ 5.7% or fasting blood glucose [FBG] ≥ 100 mg/dl at TB treatment start and HbA1c < 5.7% or FBG < 100 mg/dl within 2 months). Culture conversion was defined as two consecutive monthly negative Mtb cultures with no subsequent positive cultures. Culture conversion rates were compared by glycemic status using Kaplan Meier curves and hazards regression. Results Among 225 participants (64% of target enrollment) with culture data available to date: median age was 40 years (IQR 29-54), median BMI was 20.7 kg/m2 (IQR 18.6-23.8), and 38% were female. At enrollment, 43% had stress hyperglycemia, 17% had DM or pre-DM, and 40% had euglycemia. Overall, 200 participants (89%) achieved culture conversion by 2 months, with the lowest proportion of culture conversion in the stress hyperglycemia group (82% converted, vs 89% DM/pre-DM and 96% euglycemic; p=0.01). Median time to culture conversion was 58 days (IQR 30-62) among participants with stress hyperglycemia, compared to 59 days (IQR 31-72) among DM/pre-DM and 51 days (IQR 30-62) among euglycemic participants (Figure 1; p=0.10). After adjusting for age, sex, and baseline BMI, participants with stress hyperglycemia (HR 0.75, 95%CI 0.5-1.0) and DM/pre-DM (HR 0.72, 95%CI 0.5-1.1) had reduced culture conversion rates compared to euglycemic participants. Conclusion In preliminary analysis, we found >40% of participants had stress hyperglycemia at TB treatment initiation. Participants with stress hyperglycemia trended to have reduced culture conversion rates compared to those with euglycemia. Disclosures Francisco J. Pasquel, MD, MPH, Dexcom: Grant/Research Support|Dexcom: Grant/Research Support|Dexcom: Honoraria|Ideal Medical Technologies: Grant/Research Support|Insulet: Grant/Research Support|Novo Nordisk: Grant/Research Support|Tandem Diabetes Care: Grant/Research Support

Open Forum Infectious DiseasesVol. 13(Supplement_1)
Batumi Shota Rustaveli State University (GE), Emory University (US), University of Massachusetts Chan Medical School (US), University of Tennessee at Chattanooga (US), National Center for Tuberculosis and Lung Disease (GE), Georgia Department of Public Health (US), Rollins College (US)
Good health and well-being
Openalex Percentile: Top 91%
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.